SCHEMBL30631410

SCHEMBL30631410

Cc1nc(O)c(Br)cc1C(F)(F)F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO2 P16083 1/20 0.36
▸ DHODH Q02127 1/20 0.35
▸ CFTR P13569 2/20 0.34
▸ HTT P42858 4/20 0.33
▸ NPSR1 Q6W5P4 2/20 0.33
▸ LMNA P02545 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ NOTUM Q6P988 1/20 0.33
▸ PRNP P04156 1/20 0.33
▸ NOD2 Q9HC29 1/20 0.33
▸ ESR2 Q92731 2/20 0.33
▸ HSP90AA1 P07900 1/20 0.32
▸ HSP90AB1 P08238 1/20 0.32
▸ ESR1 P03372 1/20 0.32
▸ PTPN1 P18031 3/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26615963 1.00 NQO2 (0.36) NQO2DHODHCFTRHTTNPSR1
SCHEMBL26615783 0.77 HTT (0.33) DHODHCFTRHTTHPGDNOTUM
SCHEMBL31440810 0.77 HTT (0.33) DHODHCFTRHTTHPGDNOTUM
SCHEMBL1201473 0.74 NQO2 (0.48) NQO2HTTNPSR1LMNAHPGD
SCHEMBL31128303 0.74 NQO2 (0.39) NQO2HTTNPSR1LMNAHPGD
SCHEMBL30186062 0.73 NQO2 (0.42) NQO2HTTNPSR1LMNAHPGD
SCHEMBL15195556 0.73 NQO2 (0.42) NQO2HTTNPSR1LMNAHPGD
SCHEMBL26738670 0.72 TDP1 (0.38) DHODHCFTRHTTHPGDHSP90AA1
SCHEMBL31128300 0.71 GABRA1 (0.42) NQO2HTTNPSR1LMNAHPGD
SCHEMBL31128313 0.69 NQO2 (0.39) NQO2HTTNPSR1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119677737-A Heteroaryl compounds for the treatment of pain 沃泰克斯药物股份有限公司 2025-03-21 — — CN disclosed
EP-4511116-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN Vertex Pharmaceuticals Incorporated (US) 2025-02-26 — — EP disclosed
WO-2023205463-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-10-26 — — WO disclosed
Send feedback